TECNIS IOL DFW225 (REF DFW225U210)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TECNIS SYNERGY TORII SMPCY 21.0D CYL2.25 · Class 3 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 05050474751873), received between Jan 14, 2022 and Apr 30, 2025 — classified as 5 injuries.
The most frequently reported specific device problem is “Application Program Problem: Dose Calculation Error” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
- Application Program Problem: Dose Calculation Error1
Patient problems
- Visual Disturbances5
- Halo2
- Visual Impairment2
- Blurred Vision1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryApr 30, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE DFW225 MODEL INTRAOCULAR LENS (IOL) WAS IMPLANTED IN THE PATIENT¿S OCULAR SINISTER (LEFT EYE). IN A SECONDARY SURGICAL PROCEDURE, THE IOL WAS EXPLANTED DUE TO COMPLAINTS OF DYSPHOTOPSIA AND REPLACED WITH AN AR40E 20.0 DIOPTER IOL. DUE TO SCLERAL TUNNEL BEING PLACED, INCISION ENLARGEMENT, SCLERAL SUTURES, AND PARS PLANA VITRECTOMY WERE PERFORMED DURING THE LENS EXCHANGE PROCEDURE. SCLERAL SUTURES AND PARS PLANA VITRECTOMY WERE BOTH PLANNED AND SUTURES WERE USED AS A PROPHYLACTIC MEASURE. THERE WAS NO PATIENT INJURY. PATIENT PROGNOSIS POST LENS EXCHANGE PROCEDURE WAS REPORTED AS GOOD RESULT, PATIENT HAPPY WITH THE RESULT. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Visual Disturbances
MAUDE report 21939903 ↗InjuryFeb 18, 2025Application Program Problem: Dose Calculation Error; Application Program Problem: Dose Calculation Error
IT WAS REPORTED THAT DRY EYE CAUSED AN ERRONEOUS TOPOGRAPHY, LEADING TO THE INCORRECT PERCEPTION OF A NEED FOR A TORIC LENS. HOWEVER, THE SURGEON INTRODUCED 2 DIOPTERS OF CYLINDER. INITIALLY, THE DOCTOR PLANNED TO REMOVE THE TORIC INTRAOCULAR LENS (IOL) AND REPLACE IT WITH A NON-TORIC SYNERGY OR ODYSSEY LENS. HOWEVER, ADDITIONAL INFORMATION SUGGESTS THAT THE DOCTOR OPTED TO ROTATE THE LENS INSTEAD OF REMOVING IT. THE ROTATION WILL BE MORE THAN 10 DEGREES, SPECIFICALLY FROM 138 DEGREES TO 165 DEGREES. AS OF THE PATIENT'S LAST VISIT, THEIR UNCORRECTED VISION IMPROVED FROM 20/80 TO 20/30 AFTER THE ROTATION, AND THE PATIENT SEEMS SATISFIED WITH THE OUTCOME. FURTHER INFORMATION SUGGESTS THAT THE ROTATION OCCURRED DUE TO A PLACEMENT ISSUE. NO FURTHER TREATMENT OR INJURIES WERE REPORTED. ADDITIONAL INFORMATION RECEIVED INDICATED THAT UPON POSTOPERATIVE EXAMINATION, THE PATIENT REPORTED COMPLAINTS OF DIPLOPIA AND SHADOWING AND THESE VISUAL COMPLAINTS HAVE PERSISTED FOR SEVERAL MONTHS. THE PATIENT STATES THAT THIS IS AFFECTING ALL OF HIS DAILY ACTIVITIES. THE DOCTOR WOULD LIKE TO EXCHANGE THE IOL FOR AN ODYSSEY TORIC LENS IMPLANT. NO FURTHER DETAILS WERE PROVIDED.
Patient problems: Visual Disturbances; Visual Impairment
MAUDE report 21406588 ↗InjuryApr 12, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THE DFW225 MODEL INTRAOCULAR LENS (IOL) WAS IMPLANTED INTO THE PATIENT¿S OCULAR DEXTER (RIGHT EYE). COMPLAINTS OF BLURRED VISION, PHOTOPSIAS, GLARE, AND HALOS WERE NOTED POST-OPERATIVE DAY 1 ONWARD. BEST CORRECT VISION WAS REPORTED AS 20/25. THERE IS NO INDICATION THE PATIENT SYMPTOMS BEING REPORTED ARE DEBILITATING. THROUGH FOLLOW-UP, ADDITIONAL INFORMATION WAS RECEIVED CONFIRMING THE DFW225 IOL WAS EXPLANTED IN A SECONDARY SURGICAL PROCEDURE. THE EXPLANTED IOL WAS REPLACED WITH A DIU225 21.0 DIOPTER IOL. THERE WAS NO SERIOUS PATIENT INJURY, NO SUTURES, AND NO VITRECTOMY HOWEVER THE INCISION WAS ENLARGED - 3.0MM. PATIENT OUTCOME POST-LENS EXCHANGE WAS REPORTED AS 20/40 UNCORRECTED ON POST OP-DAY 1. THE SUSPECT IOL IS NOT AVAILABLE FOR RETURN AS IT WAS DISCARDED. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Blurred Vision; Halo; Visual Disturbances
MAUDE report 19102361 ↗InjuryMar 1, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THE INTRAOCULAR LENS (IOL) WAS IMPLANTED IN THE RIGHT EYE AND THEN EXPLANTED MONTHS LATER DUE TO THE PATIENT EXPERIENCING VERY BOTHERSOME HALOS AND GLARE WHEN DRIVING AT NIGHT, WHICH SEEMED WORSE AROUND RED LIGHTS. THE PATIENT REQUESTED TO HAVE THE IOL REMOVED. THE PROCEDURE WAS COMPLETED USING A COMPETITOR IOL (MODEL: LIGHT ADJUSTABLE). THE OUTCOME DID NOT SIGNIFICANTLY INTERFERE WITH THE PATIENT'S ACTIVITIES OF DAILY LIFE. THE CURRENT PATIENT STATUS IS UNKNOWN. THE EXPLANTED IOL WAS DISCARDED. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Halo; Visual Disturbances
MAUDE report 13642380 ↗InjuryJan 14, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
CUSTOMER REPORTED THAT AFTER IMPLANTING THE JOHNSON & JOHNSON INTRAOCULAR LENS (IOL), THEIR PATIENT HAS HAD TWO RESIDUAL DIFFICULTIES. PATIENT HAS ALWAYS FELT THAT THERE WAS SIGNIFICANT GLARE, VISUAL DISTURBANCE WITH THE MULTIFOCAL LENSES. THIS HAS INTERFERED SIGNIFICANTLY WITH HER DRIVING ABILITY AS WELL AS ANY BRIGHT LIGHTS SITUATIONS. ADDITIONALLY, THE DOCTOR REPORTED THAT SHE HAS BEEN FOUND TO HAVE SOME IRREGULAR ASTIGMATISM AND SOME RESIDUAL NEARSIGHTEDNESS, PRESBYOPIA AFTER THE COUNTER ACTIVITY. FOR ALL OF THE MENTIONED REASONS AND AFTER A LONG DISCUSSION, THE DOCTOR DECIDED TO DO A LENS EXCHANGE OF THE LENS IN THE RIGHT EYE WITH A CONVENTIONAL LENS AIMING FOR DISTANCE VISION AND PLANNING TO GET GLASSES AFTERWARDS FOR A FINAL IMPROVED REFRACTION. THE REPLACEMENT LENS IS MODEL DIB00 19.5 DIOPTER. NO CAPSULE TEAR WAS REPORTED AND NO SURGICAL OR MEDICAL INTERVENTION SUCH AS INCISION ENLARGEMENT, VITRECTOMY, OR SUTURES. THE PATIENT OUTCOME POST-OP IS TO BE DETERMINED DURING THEIR POST-OP PERIOD. THERE WAS NO PATIENT INJURY REPORTED. NO FURTHER INFORMATION WAS PROVIDED.
Patient problems: Visual Disturbances; Visual Impairment
MAUDE report 13262395 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page